A new strategy developed by scientists in the Albert Einstein College of Medicine makes pancreatic tumours visible to the immune systems of mice and vulnerable to immune attacks, reducing cancer metastases by 87%.
First-ever clinical treatment for cancer prevention was done in the UK to keep cancer at bay.